Title: The PARN, TOE1, and USB1 RNA deadenylases and their roles in non-coding RNA regulation
Abstract: The levels of non-coding RNAs (ncRNAs) are regulated by transcription, RNA processing, and RNA degradation pathways. One mechanism for the degradation of ncRNAs involves the addition of oligo(A) tails by non-canonical poly(A) polymerases, which then recruit processive sequence-independent 3′ to 5′ exonucleases for RNA degradation. This pathway of decay is also regulated by three 3′ to 5′ exoribonucleases, USB1, PARN, and TOE1, which remove oligo(A) tails and thereby can protect ncRNAs from decay in a manner analogous to the deubiquitination of proteins. Loss-of-function mutations in these genes lead to premature degradation of some ncRNAs and lead to specific human diseases such as Poikiloderma with Neutropenia (PN) for USB1, Dyskeratosis Congenita (DC) for PARN and Pontocerebellar Hypoplasia type 7 (PCH7) for TOE1. Herein, we review the biochemical properties of USB1, PARN, and TOE1, how they modulate ncRNA levels, and their roles in human diseases. The levels of non-coding RNAs (ncRNAs) are regulated by transcription, RNA processing, and RNA degradation pathways. One mechanism for the degradation of ncRNAs involves the addition of oligo(A) tails by non-canonical poly(A) polymerases, which then recruit processive sequence-independent 3′ to 5′ exonucleases for RNA degradation. This pathway of decay is also regulated by three 3′ to 5′ exoribonucleases, USB1, PARN, and TOE1, which remove oligo(A) tails and thereby can protect ncRNAs from decay in a manner analogous to the deubiquitination of proteins. Loss-of-function mutations in these genes lead to premature degradation of some ncRNAs and lead to specific human diseases such as Poikiloderma with Neutropenia (PN) for USB1, Dyskeratosis Congenita (DC) for PARN and Pontocerebellar Hypoplasia type 7 (PCH7) for TOE1. Herein, we review the biochemical properties of USB1, PARN, and TOE1, how they modulate ncRNA levels, and their roles in human diseases. Gene expression in eukaryotes is regulated at multiple levels. While transcription regulation plays an important role, the regulation of RNA processing and degradation are also important in modulating the levels of both mRNAs and non-coding RNAs (ncRNAs) (1Lu P. Vogel C. Wang R. Yao X. Marcotte E.M. Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation.Nat. Biotechnol. 2007; 25: 117-124Crossref PubMed Scopus (922) Google Scholar). After transcription, 3′-end modifications of mRNA molecules can modulate the fate of newly synthesized RNAs. The 3′ ends of mRNAs are dynamically changed by the opposing effects of poly(A) polymerases and exonucleases, which can affect all aspects of mRNA metabolism (2Yan Y.B. Deadenylation: enzymes, regulation, and functional implications.Wiley Interdiscip. Rev. RNA. 2014; 5: 421-443Crossref PubMed Scopus (32) Google Scholar). For example, the addition of poly(A) tails to mRNAs promotes their processing, export, and translation (3Darnell J.E. Philipson L. Wall R. Adesnik M. Polyadenylic acid sequences: role in conversion of nuclear RNA into messenger RNA.Science. 1971; 174: 507-510Crossref PubMed Google Scholar, 4Edmonds M. Vaughan M.H. Nakazato H. Polyadenylic acid sequences in the heterogeneous nuclear RNA and rapidly-labeled polyribosomal RNA of HeLa cells: possible evidence for a precursor relationship.Proc. Natl. Acad. Sci. U. S. A. 1971; 68: 1336-1340Crossref PubMed Google Scholar, 5Niwa M. Rose S.D. Berget S.M. In vitro polyadenylation is stimulated by the presence of an upstream intron.Genes Dev. 1990; 4: 1552-1559Crossref PubMed Google Scholar, 6Wassarman K.M. Steitz J.A. Association with terminal exons in pre-mRNAs: a new role for the U1 snRNP?.Genes Dev. 1993; 7: 647-659Crossref PubMed Google Scholar, 7Dreyfus M. Régnier P. The poly(A) tail of mRNAs: bodyguard in eukaryotes, scavenger in Bacteria.Cell. 2002; 111: 611-613Abstract Full Text Full Text PDF PubMed Scopus (197) Google Scholar). Moreover, 3′ poly(A) tails on mRNAs can increase their stability by reducing the rate of decapping and/or inhibiting access to 3′ to 5′ exonucleases (8Łabno A. Tomecki R. Dziembowski A. Cytoplasmic RNA decay pathways - enzymes and mechanisms.Biochim. Biophys. Acta. 2016; 1863: 3125-3147Crossref PubMed Scopus (126) Google Scholar). Similarly, 3′-end modifications of ncRNAs can regulate RNA processing and/or degradation. For instance, the addition of CCA to tRNA and uridylation of U6 small nuclear RNA (snRNA) are involved in RNA maturation (9Sprinzl M. Cramer F. The -C-C-A end of tRNA and its role in protein biosynthesis.Prog. Nucleic Acid Res. Mol. Biol. 1979; 22: 1-69Crossref PubMed Scopus (137) Google Scholar, 10Deutscher M.P. Ni R.C. Purification of a low molecular weight form of rat liver arginyl-tRNA synthetase.J. Biol. Chem. 1982; 257: 6003-6006Abstract Full Text PDF PubMed Google Scholar, 11Reddy R. Henning D. Das G. Harless M. Wright D. The capped U6 small nuclear RNA is transcribed by RNA polymerase III.J. Biol. Chem. 1987; 262: 75-81Abstract Full Text PDF PubMed Google Scholar), and the monouridylation of let-7 pre-miRNA by TUT4/TUT7 enhances its processing into mature let-7 (12Heo I. Joo C. Cho J. Ha M. Han J. Kim V.N. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA.Mol. Cell. 2008; 32: 276-284Abstract Full Text Full Text PDF PubMed Scopus (798) Google Scholar). In contrast, other polymerases can promote degradation. For example, non-canonical poly(A) polymerases of the TRAMP complex interact with the nuclear exosome complex and are involved in the 3′-end processing and degradation of rRNAs and snoRNAs (13LaCava J. Houseley J. Saveanu C. Petfalski E. Thompson E. Jacquier A. et al.RNA degradation by the exosome is promoted by a nuclear polyadenylation complex.Cell. 2005; 121: 713-724Abstract Full Text Full Text PDF PubMed Scopus (700) Google Scholar, 14Vanácová S. Wolf J. Martin G. Blank D. Dettwiler S. Friedlein A. et al.A new yeast poly(A) polymerase complex involved in RNA quality control.PLoS Biol. 2005; 3: e189Crossref PubMed Scopus (0) Google Scholar, 15Wyers F. Rougemaille M. Badis G. Rousselle J.C. Dufour M.E. Boulay J. et al.Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase.Cell. 2005; 121: 725-737Abstract Full Text Full Text PDF PubMed Scopus (674) Google Scholar). Likewise, the uridylation of target RNAs, such as uridylation of let-7 pre-miRNA by TUT4/TUT7, or histone mRNAs (16Marzluff W.F. Koreski K.P. Birth and death of histone mRNAs.Trends Genet. 2017; 33: 745-759Abstract Full Text Full Text PDF PubMed Scopus (104) Google Scholar), can recruit exonucleases for RNA degradation (13LaCava J. Houseley J. Saveanu C. Petfalski E. Thompson E. Jacquier A. et al.RNA degradation by the exosome is promoted by a nuclear polyadenylation complex.Cell. 2005; 121: 713-724Abstract Full Text Full Text PDF PubMed Scopus (700) Google Scholar, 14Vanácová S. Wolf J. Martin G. Blank D. Dettwiler S. Friedlein A. et al.A new yeast poly(A) polymerase complex involved in RNA quality control.PLoS Biol. 2005; 3: e189Crossref PubMed Scopus (0) Google Scholar, 15Wyers F. Rougemaille M. Badis G. Rousselle J.C. Dufour M.E. Boulay J. et al.Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase.Cell. 2005; 121: 725-737Abstract Full Text Full Text PDF PubMed Scopus (674) Google Scholar, 17Jia H. Wang X. Liu F. Guenther U.P. Srinivasan S. Anderson J.T. et al.The RNA helicase Mtr4p modulates polyadenylation in the TRAMP complex.Cell. 2011; 145: 890-901Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar, 18Hagan J.P. Piskounova E. Gregory R.I. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells.Nat. Struct. Mol. Biol. 2009; 16: 1021-1025Crossref PubMed Scopus (415) Google Scholar, 19Chang H.M. Triboulet R. Thornton J.E. Gregory R.I. A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway.Nature. 2013; 497: 244-248Crossref PubMed Scopus (0) Google Scholar, 20Ustianenko D. Hrossova D. Potesil D. Chalupnikova K. Hrazdilova K. Pachernik J. et al.Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs.RNA. 2013; 19: 1632-1638Crossref PubMed Scopus (130) Google Scholar, 21Rissland O.S. Norbury C.J. Decapping is preceded by 3' uridylation in a novel pathway of bulk mRNA turnover.Nat. Struct. Mol. Biol. 2009; 16: 616-623Crossref PubMed Scopus (0) Google Scholar). Oligo(A) tail addition can also promote the degradation of some ncRNAs. For example, oligoadenylation by PAPD5/PAPD7 of miRNAs, human telomerase RNA (hTR), Y RNAs, ribosomal RNAs (rRNAs), small nucleolar RNAs (snoRNAs), small Cajal body-specific RNAs (scaRNAs), and small nuclear RNAs (snRNAs) can recruit exonucleases to degrade the RNAs (22Shukla S. Schmidt J.C. Goldfarb K.C. Cech T.R. Parker R. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.Nat. Struct. Mol. Biol. 2016; 23: 286-292Crossref PubMed Google Scholar, 23Shukla S. Parker R. PARN modulates Y RNA stability and its 3'-end formation.Mol. Cell. Biol. 2017; 37: e00264-e00317Crossref PubMed Scopus (27) Google Scholar, 24Shukla S. Bjerke G.A. Muhlrad D. Yi R. Parker R. The RNase PARN controls the levels of specific miRNAs that contribute to p53 regulation.Mol. Cell. 2019; 73: 1204-1216.e1204Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar, 25Nguyen D. Grenier St-Sauveur V. Bergeron D. Dupuis-Sandoval F. Scott M.S. Bachand F. A polyadenylation-dependent 3' end maturation pathway is required for the Synthesis of the human telomerase RNA.Cell Rep. 2015; 13: 2244-2257Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 26Tseng C.K. Wang H.F. Burns A.M. Schroeder M.R. Gaspari M. Baumann P. Human telomerase RNA processing and quality control.Cell Rep. 2015; 13: 2232-2243Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar, 27Moon D.H. Segal M. Boyraz B. Guinan E. Hofmann I. Cahan P. et al.Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.Nat. Genet. 2015; 47: 1482-1488Crossref PubMed Scopus (0) Google Scholar, 28Boele J. Persson H. Shin J.W. Ishizu Y. Newie I.S. Søkilde R. et al.PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.Proc. Natl. Acad. Sci. U. S. A. 2014; 111: 11467-11472Crossref PubMed Scopus (110) Google Scholar, 29Berndt H. Harnisch C. Rammelt C. Stöhr N. Zirkel A. Dohm J.C. et al.Maturation of mammalian H/ACA box snoRNAs: PAPD5-dependent adenylation and PARN-dependent trimming.RNA. 2012; 18: 958-972Crossref PubMed Scopus (119) Google Scholar, 30Son A. Park J.E. Kim V.N. PARN and TOE1 Constitute a 3' end maturation Module for nuclear non-coding RNAs.Cell Rep. 2018; 23: 888-898Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar). Similarly, PAPD5-mediated adenylation has been proposed to destabilize miR-21 and hTR RNAs in human cancer cell lines (22Shukla S. Schmidt J.C. Goldfarb K.C. Cech T.R. Parker R. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.Nat. Struct. Mol. Biol. 2016; 23: 286-292Crossref PubMed Google Scholar, 25Nguyen D. Grenier St-Sauveur V. Bergeron D. Dupuis-Sandoval F. Scott M.S. Bachand F. A polyadenylation-dependent 3' end maturation pathway is required for the Synthesis of the human telomerase RNA.Cell Rep. 2015; 13: 2244-2257Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 26Tseng C.K. Wang H.F. Burns A.M. Schroeder M.R. Gaspari M. Baumann P. Human telomerase RNA processing and quality control.Cell Rep. 2015; 13: 2232-2243Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar, 27Moon D.H. Segal M. Boyraz B. Guinan E. Hofmann I. Cahan P. et al.Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.Nat. Genet. 2015; 47: 1482-1488Crossref PubMed Scopus (0) Google Scholar, 28Boele J. Persson H. Shin J.W. Ishizu Y. Newie I.S. Søkilde R. et al.PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.Proc. Natl. Acad. Sci. U. S. A. 2014; 111: 11467-11472Crossref PubMed Scopus (110) Google Scholar). As oligo(A) tails can promote RNA degradation, it is not surprising that a set of deadenylases can remove oligo(A) tails and thereby stabilize some ncRNAs. To date, there are three such ncRNA deadenylases that can regulate ncRNAs in this manner including the poly(A) specific ribonuclease (PARN), USB1 (also called Mpn1), and Target of Erg1 (TOE1, also called Caf1z). Recent studies have shown that these enzymes regulate the stability of several ncRNAs in mammalian cells, such as hTR, Y RNAs, piwi-interacting RNAs (piRNAs), and miRNAs by removing poly(A) tails added by PAPD5/7. The poly(A) tail removal limits the recruitment of exonucleases DIS3L, DIS3L2, and/or the nuclease exosome (22Shukla S. Schmidt J.C. Goldfarb K.C. Cech T.R. Parker R. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.Nat. Struct. Mol. Biol. 2016; 23: 286-292Crossref PubMed Google Scholar, 23Shukla S. Parker R. PARN modulates Y RNA stability and its 3'-end formation.Mol. Cell. Biol. 2017; 37: e00264-e00317Crossref PubMed Scopus (27) Google Scholar, 24Shukla S. Bjerke G.A. Muhlrad D. Yi R. Parker R. The RNase PARN controls the levels of specific miRNAs that contribute to p53 regulation.Mol. Cell. 2019; 73: 1204-1216.e1204Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar, 25Nguyen D. Grenier St-Sauveur V. Bergeron D. Dupuis-Sandoval F. Scott M.S. Bachand F. A polyadenylation-dependent 3' end maturation pathway is required for the Synthesis of the human telomerase RNA.Cell Rep. 2015; 13: 2244-2257Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 26Tseng C.K. Wang H.F. Burns A.M. Schroeder M.R. Gaspari M. Baumann P. Human telomerase RNA processing and quality control.Cell Rep. 2015; 13: 2232-2243Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar, 27Moon D.H. Segal M. Boyraz B. Guinan E. Hofmann I. Cahan P. et al.Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.Nat. Genet. 2015; 47: 1482-1488Crossref PubMed Scopus (0) Google Scholar, 28Boele J. Persson H. Shin J.W. Ishizu Y. Newie I.S. Søkilde R. et al.PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.Proc. Natl. Acad. Sci. U. S. A. 2014; 111: 11467-11472Crossref PubMed Scopus (110) Google Scholar, 29Berndt H. Harnisch C. Rammelt C. Stöhr N. Zirkel A. Dohm J.C. et al.Maturation of mammalian H/ACA box snoRNAs: PAPD5-dependent adenylation and PARN-dependent trimming.RNA. 2012; 18: 958-972Crossref PubMed Scopus (119) Google Scholar, 30Son A. Park J.E. Kim V.N. PARN and TOE1 Constitute a 3' end maturation Module for nuclear non-coding RNAs.Cell Rep. 2018; 23: 888-898Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 31Jeong H.C. Shukla S. Fok W.C. Huynh T.N. Batista L.F.Z. Parker R. USB1 is a miRNA deadenylase that regulates hematopoietic development.Science. 2023; 379: 901-907Crossref PubMed Scopus (3) Google Scholar, 32Lardelli R.M. Schaffer A.E. Eggens V.R. Zaki M.S. Grainger S. Sathe S. et al.Biallelic mutations in the 3' exonuclease TOE1 cause pontocerebellar hypoplasia and uncover a role in snRNA processing.Nat. Genet. 2017; 49: 457-464Crossref PubMed Scopus (0) Google Scholar, 33Lardelli R.M. Lykke-Andersen J. Competition between maturation and degradation drives human snRNA 3' end quality control.Genes Dev. 2020; 34: 989-1001Crossref PubMed Google Scholar, 34Deng T. Huang Y. Weng K. Lin S. Li Y. Shi G. et al.TOE1 acts as a 3' exonuclease for telomerase RNA and regulates telomere maintenance.Nucleic Acids Res. 2019; 47: 391-405Crossref PubMed Scopus (0) Google Scholar, 35Ustianenko D. Pasulka J. Feketova Z. Bednarik L. Zigackova D. Fortova A. et al.TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs.EMBO J. 2016; 35: 2179-2191Crossref PubMed Scopus (69) Google Scholar, 36Izumi N. Shoji K. Sakaguchi Y. Honda S. Kirino Y. Suzuki T. et al.Identification and functional analysis of the pre-piRNA 3' Trimmer in Silkworms.Cell. 2016; 164: 962-973Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 37Tang W. Tu S. Lee H.C. Weng Z. Mello C.C. The RNase PARN-1 Trims piRNA 3' ends to promote transcriptome surveillance in C. elegans.Cell. 2016; 164: 974-984Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar). The process of oligo(A) tail addition and removal regulating the degradation of ncRNAs can be considered analogous to the control of protein degradation by ubiquination and deubiquination (Fig. 1). In this analogy, the oligo(A) polymerases such as PAPD5/7 are analogous to E3 ubiquitin ligases. Moreover, the recent results showing that PARN, TOE1, and USB1 stabilize different ncRNAs by removing these oligo(A) tails suggest this group of enzymes functions analogously to deubiquitinases. This suggests an emerging and unappreciated commonality of function for the USB1, TOE1, and PARN enzymes. Consistent with a commonality of function, USB1, PARN, and TOE1 are each connected to a specific human disease (32Lardelli R.M. Schaffer A.E. Eggens V.R. Zaki M.S. Grainger S. Sathe S. et al.Biallelic mutations in the 3' exonuclease TOE1 cause pontocerebellar hypoplasia and uncover a role in snRNA processing.Nat. Genet. 2017; 49: 457-464Crossref PubMed Scopus (0) Google Scholar, 38Burris A.M. Ballew B.J. Kentosh J.B. Turner C.E. Norton S.A. Giri N. et al.Hoyeraal-hreidarsson syndrome due to PARN mutations: fourteen years follow-up.Pediatr. Neurol. 2016; 56: 62-68.e61Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 39Dhanraj S. Gunja S.M. Deveau A.P. Nissbeck M. Boonyawat B. Coombs A.J. et al.Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN).J. Med. Genet. 2015; 52: 738-748Crossref PubMed Google Scholar, 40Stuart B.D. Choi J. Zaidi S. Xing C. Holohan B. Chen R. et al.Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening.Nat. Genet. 2015; 47: 512-517Crossref PubMed Scopus (327) Google Scholar, 41Tummala H. Walne A. Collopy L. Cardoso S. de la Fuente J. Lawson S. et al.Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita.J. Clin. Invest. 2015; 125: 2151-2160Crossref PubMed Scopus (139) Google Scholar, 42Concolino D. Roversi G. Muzzi G.L. Sestito S. Colombo E.A. Volpi L. et al.Clericuzio-type poikiloderma with neutropenia syndrome in three sibs with mutations in the C16orf57 gene: delineation of the phenotype.Am. J. Med. Genet. A. 2010; 152A: 2588-2594Crossref PubMed Scopus (0) Google Scholar, 43Volpi L. Roversi G. Colombo E.A. Leijsten N. Concolino D. Calabria A. et al.Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene.Am. J. Hum. Genet. 2010; 86: 72-76Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar, 44Tanaka A. Morice-Picard F. Lacombe D. Nagy N. Hide M. Taïeb A. et al.Identification of a homozygous deletion mutation in C16orf57 in a family with Clericuzio-type poikiloderma with neutropenia.Am. J. Med. Genet. A. 2010; 152A: 1347-1348PubMed Google Scholar, 45Wang C. Ge Y. Li R. He G. Lin Y. Novel compound heterozygous missense variants in TOE1 gene associated with pontocerebellar hypoplasia type 7.Gene. 2023; 862147250Crossref Scopus (1) Google Scholar, 46Zhang D. Zhou Z. Abu-Hijleh M. Batra K. Xing C. Garcia C.K. Homozygous rare PARN missense mutation in familial pulmonary fibrosis.Am. J. Respir. Crit. Care Med. 2019; 199: 797-799Crossref PubMed Scopus (11) Google Scholar, 47Kropski J.A. Reiss S. Markin C. Brown K.K. Schwartz D.A. Schwarz M.I. et al.Rare genetic variants in PARN are associated with pulmonary fibrosis in families.Am. J. Respir. Crit. Care Med. 2017; 196: 1481-1484Crossref PubMed Scopus (26) Google Scholar, 48Walne A.J. Vulliamy T. Beswick R. Kirwan M. Dokal I. Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome.Hum. Mol. Genet. 2010; 19: 4453-4461Crossref PubMed Scopus (81) Google Scholar). For example, loss-of-function mutations in USB1 (USB1 mutants) lead to the genetic disorder Poikiloderma with Neutropenia (PN), an autosomal-recessive bone marrow failure (BMF) syndrome with marked clinical overlap with Dyskeratosis Congenita (DC) (49Walne A.J. Collopy L. Cardoso S. Ellison A. Plagnol V. Albayrak C. et al.Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis.Haematologica. 2016; 101: 1180-1189Crossref PubMed Scopus (32) Google Scholar). In contrast, loss-of-function mutations in PARN (PARN mutants) cause a severe form of DC called Hoyeraal-Hreidarsson syndrome, which causes abnormally short telomeres and congenital defects (38Burris A.M. Ballew B.J. Kentosh J.B. Turner C.E. Norton S.A. Giri N. et al.Hoyeraal-hreidarsson syndrome due to PARN mutations: fourteen years follow-up.Pediatr. Neurol. 2016; 56: 62-68.e61Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 39Dhanraj S. Gunja S.M. Deveau A.P. Nissbeck M. Boonyawat B. Coombs A.J. et al.Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN).J. Med. Genet. 2015; 52: 738-748Crossref PubMed Google Scholar, 40Stuart B.D. Choi J. Zaidi S. Xing C. Holohan B. Chen R. et al.Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening.Nat. Genet. 2015; 47: 512-517Crossref PubMed Scopus (327) Google Scholar, 41Tummala H. Walne A. Collopy L. Cardoso S. de la Fuente J. Lawson S. et al.Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita.J. Clin. Invest. 2015; 125: 2151-2160Crossref PubMed Scopus (139) Google Scholar) and idiopathic pulmonary fibrosis (IPF) (40Stuart B.D. Choi J. Zaidi S. Xing C. Holohan B. Chen R. et al.Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening.Nat. Genet. 2015; 47: 512-517Crossref PubMed Scopus (327) Google Scholar). Finally, biallelic loss-of-function mutations in TOE1 (TOE1 mutants) cause Pontocerebellar Hypoplasia type 7 (PCH7), a unique recessive syndrome characterized by neurodegeneration with ambiguous genitalia (32Lardelli R.M. Schaffer A.E. Eggens V.R. Zaki M.S. Grainger S. Sathe S. et al.Biallelic mutations in the 3' exonuclease TOE1 cause pontocerebellar hypoplasia and uncover a role in snRNA processing.Nat. Genet. 2017; 49: 457-464Crossref PubMed Scopus (0) Google Scholar, 45Wang C. Ge Y. Li R. He G. Lin Y. Novel compound heterozygous missense variants in TOE1 gene associated with pontocerebellar hypoplasia type 7.Gene. 2023; 862147250Crossref Scopus (1) Google Scholar). Herein, we review the properties of USB1, PARN, and TOE1, and their roles in RNA regulation. As mutations in these enzymes lead to human diseases, understanding their functions and targets may provide insights into treatments for these diseases. USB1 is a member of the 2H phosphodiesterase superfamily, which can be subdivided into H x T and H x S enzymes, the latter of which contains USB1 (50Mazumder R. Iyer L.M. Vasudevan S. Aravind L. Detection of novel members, structure-function analysis and evolutionary classification of the 2H phosphoesterase superfamily.Nucleic Acids Res. 2002; 30: 5229-5243Crossref PubMed Scopus (129) Google Scholar). The 2H phosphodiesterase superfamily is an enzyme family with 2′,3′-cyclic or 1′,2′-cyclic phosphodiesterase (CPDase) activity, 3′-5′ or 2′-5′ phosphodiesterase activity, or 2′,5′-RNA ligase activity. The active sites of these enzymes all utilize two catalytic histidines within the central H x S/T tetrapeptide motifs that act as a general acid and base, while the serine or threonine residues help coordinate substrates and assist in transition state stabilization (51Shchepachev V. Wischnewski H. Missiaglia E. Soneson C. Azzalin C.M. Mpn1, mutated in poikiloderma with neutropenia protein 1, is a conserved 3'-to-5' RNA exonuclease processing U6 small nuclear RNA.Cell Rep. 2012; 2: 855-865Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 52Arn E.A. Abelson J.N. The 2'-5' RNA ligase of Escherichia coli. Purification, cloning, and genomic disruption.J. Biol. Chem. 1996; 271: 31145-31153Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 53Hofmann A. Zdanov A. Genschik P. Ruvinov S. Filipowicz W. Wlodawer A. Structure and mechanism of activity of the cyclic phosphodiesterase of Appr>p, a product of the tRNA splicing reaction.EMBO J. 2000; 19: 6207-6217Crossref PubMed Scopus (52) Google Scholar, 54Kato M. Shirouzu M. Terada T. Yamaguchi H. Murayama K. Sakai H. et al.Crystal structure of the 2'-5' RNA ligase from Thermus thermophilus HB8.J. Mol. Biol. 2003; 329: 903-911Crossref PubMed Scopus (0) Google Scholar, 55Sawaya R. Schwer B. Shuman S. Genetic and biochemical analysis of the functional domains of yeast tRNA ligase.J. Biol. Chem. 2003; 278: 43928-43938Abstract Full Text Full Text PDF PubMed Scopus (67) Google Scholar, 56Remus B.S. Jacewicz A. Shuman S. Structure and mechanism of E. coli RNA 2',3'-cyclic phosphodiesterase.RNA. 2014; 20: 1697-1705Crossref PubMed Scopus (0) Google Scholar, 57Nomura Y. Roston D. Montemayor E.J. Cui Q. Butcher S.E. Structural and mechanistic basis for preferential deadenylation of U6 snRNA by Usb1.Nucleic Acids Res. 2018; 46: 11488-11501Crossref PubMed Scopus (10) Google Scholar). In the USB1 family members, these key histidines are His120 and His208 in human USB1 (PDB ID 6D30 and 6D2Z) (Fig. 2), His109 and His199 in fission yeast (S. pombe) USB1, and His133 and His231 in budding yeast (Saccharomyces cerevisiae) (PDB ID 5UQJ). Although the overall sequence conservation can be rather low between family members, all known crystal structures of 2H family members, including USB1, display a characteristic fold with conserved terminal and transit lobes and the H x S/T motifs centrally positioned in a substrate binding cleft (53Hofmann A. Zdanov A. Genschik P. Ruvinov S. Filipowicz W. Wlodawer A. Structure and mechanism of activity of the cyclic phosphodiesterase of Appr>p, a product of the tRNA splicing reaction.EMBO J. 2000; 19: 6207-6217Crossref PubMed Scopus (52) Google Scholar, 57Nomura Y. Roston D. Montemayor E.J. Cui Q. Butcher S.E. Structural and mechanistic basis for preferential deadenylation of U6 snRNA by Usb1.Nucleic Acids Res. 2018; 46: 11488-11501Crossref PubMed Scopus (10) Google Scholar, 58Hilcenko C. Simpson P.J. Finch A.J. Bowler F.R. Churcher M.J. Jin L. et al.Aberrant 3' oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia.Blood. 2013; 121: 1028-1038Crossref PubMed Scopus (0) Google Scholar, 59Gao Y.G. Yao M. Okada A. Tanaka I. The structure of Pyrococcus horikoshii 2'-5' RNA ligase at 1.94 A resolution reveals a possible open form with a wider active-site cleft.Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2006; 62: 1196-1200Crossref PubMed Scopus (7) Google Scholar, 60Hofmann A. Grella M. Botos I. Filipowicz W. Wlodawer A. Crystal structures of the semireduced and inhibitor-bound forms of cyclic nucleotide phosphodiesterase from Arabidopsis thaliana.J. Biol. Chem. 2002; 277: 1419-1425Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar, 61Gold M.G. Smith F.D. Scott J.D. Barford D. AKAP18 contains a phosphoesterase domain that binds AMP.J. Mol. Biol. 2008; 375: 1329-1343Crossref PubMed Scopus (50) Google Scholar, 62Myllykoski M. Raasakka A. Han H. Kursula P. Myelin 2',3'-cyclic nucleotide 3'-phosphodiesterase: active-site ligand binding and molecular conformation.PLoS One. 2012; 7e32336Crossref PubMed Scopus (27) Google Scholar, 63Myllykoski M. Raasakka A. Lehtimäki M. Han H. Kursula I. Kursula P. Crystallographic analysis of the reaction cycle of 2',3'-cyclic nucleotide 3'-phosphodiesterase, a unique member of the 2H phosphoesterase family.J. Mol. Biol. 2013; 425: 4307-4322Crossref PubMed Scopus (0) Google Scholar, 64Didychuk A.L. Montemayor E.J. Carrocci T.J. DeLaitsch A.T. Lucarelli S.E. Westler W.M. et al.Usb1 controls U6 snRNP assembly through evolutionarily divergent cyclic phosphodiesterase activities.Nat. Commun. 2017; 8: 497Crossref PubMed Scopus (14) Google Scholar, 65Raasakka A. Myllykoski M. Laulumaa S. Lehtimäki M. Härtlein M. Moulin M. et al.Determinants of ligand binding and catalytic activity in the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.Sci. Rep. 2015; 516520Crossref PubMed Scopus (18) Google Scholar, 66Myllykoski M. Kursula P. Structural aspects of nucleotide ligand binding by a bacterial 2H phosphoesterase.PLoS One. 2017; 12e0170355Crossref PubMed Scopus (5) Google Scholar). In contrast, PARN and TOE1 belong to the DEDD protein superfamily, one of the six exoribonuclease superfamilies (67Zuo Y. Deutscher M.P. Exoribonuclease superfamilies: structural analysis and phylogenetic distribution.Nucleic Acids Res. 2001; 29: 1017-1026Crossref PubMed Google Scholar, 68Goldstrohm A.C. Wickens M. Multifunctional deadenylase complexes diversify mRNA control.Nat. Rev. Mol. Cell Biol. 2008; 9: 337-344Crossref PubMed Scopus (311) Google Scholar). Exoribonucleases in the DEDD superfamily are part of the much larger exonuclease superfamily, containing the proofreading domains of many DNA polymerases as well as other DNA exonucleases (69Moser M.J. Holley W.R. Chatterjee A. Mian I.S. The proofreading domain of Escherichia coli DNA polymerase I and other DNA and/or RNA exonuclease domain